Definition of a Medical Device in Canada

1. Key takeaways

Health Canada defines a medical device as any instrument or component used for the treatment, diagnosis, or prevention of a disease or abnormal physical condition. The definition expressly excludes devices used for animals or for veterinary purposes. For combination products, the licence requirements depend on whether the product is classified as a drug or as a device: products classified as devices are subject to the MDEL requirements, while products classified as drugs are subject to the DEL requirements.

• The statutory definition turns on the intended therapeutic, diagnostic, or preventive purpose, and it covers instruments as well as components.
• Devices for animal or veterinary use sit outside the definition altogether.
• Components and accessories supplied on their own can fall within the definition, not only complete systems.
• Specific product categories can carry dedicated classification conclusions, such as the Class II status of devices that deliver drugs through smoking.

2. Legal basis

The table below lists the sources relied upon for the definition of a medical device in Canada, together with the relevant provisions, dates, and official locations.

3. Expert insights

Insight one: the word component in the definition covers accessories and parts.

The official wording used by Health Canada is any instrument or component. The practical consequence is that a product supplied to the end user as a component or an accessory in its own right may also fall within the scope of a medical device, and it cannot be assessed only as part of the complete system it accompanies. A company marketing spare parts, attachments, or consumable accessories must therefore run its own determination for each item, because the fact that the parent device has already been assessed does not automatically settle the status of the parts that are sold separately. The assessment of a component should look at the purpose the component itself serves for the user, since a part that carries its own treatment or diagnostic function sits within the definition even when the complete system does not rely on it for that function.

Insight two: devices for veterinary use are expressly excluded.

The official Health Canada page states that medical devices do not include devices intended for animals or for veterinary purposes. This is an exclusion at the level of the definition itself, not a difference in the intensity of oversight, and it means the product is simply outside the Canadian medical device framework rather than subject to lighter requirements within it. Products that serve both human and veterinary users must be assessed on the basis of their human use, since that is the use the definition addresses. Where a product family contains both human and veterinary variants, the two lines should be separated at the documentation level from the start, so that the veterinary variant never enters a device dossier that was built for the human variant.

Insight three: for combination products the classification conclusion decides the licence framework, and early contact with the regulator matters.

According to GUI-0016, a combination product classified as a drug is subject to the DEL requirements of Part C, Division 1A of the Food and Drug Regulations and the relevant provisions of the Food and Drugs Act, while a combination product classified as a medical device is subject to the MDEL requirements of section 44 of the Medical Devices Regulations and its related provisions. GUI-0016 expressly recommends contacting Health Canada to confirm the classification before an application is submitted, so the confirmation conversation should be scheduled early rather than treated as an afterthought once documents are complete.

Insight four: certain products carry dedicated classification conclusions.

Both the official Health Canada page and GUI-0016 state that a medical device that is manufactured, sold, or represented for delivering a drug, including medical cannabis, to a patient through smoking, meaning smoke obtained after the drug is burned and then inhaled, is a Class II medical device. A dedicated conclusion of this kind takes precedence over any presumption that the general classification rules might otherwise produce for the product, so the first step for such products is to check whether an official dedicated conclusion already exists before working through the general rules.

4. Practical recommendations

• Use a definition determination table and record each element in turn: whether the item is an instrument or a component, whether it has a statutory intended purpose, and whether it is for veterinary use. Keep the completed table with the project file so that reviewers can trace the conclusion back to the definition.
• For combination products, confirm the classification conclusion with Health Canada first, and only then decide whether the project proceeds under the DEL framework or the MDEL framework.
• When accessories and components are assessed separately, judge them by their end-market sales form rather than by decomposing the complete system.
• For product types that already have an official dedicated classification conclusion, such as devices delivering drugs for inhalation, apply that conclusion directly.
• Document the determination conclusion in writing and file it as an input to the later dossier.

5. Verification checklist

• □ The definition determination table is complete (instrument or component, intended purpose, veterinary exclusion)
• □ Accessories and components have been assessed on their own
• □ For combination products, a classification conclusion has been obtained or an application for one is under way
• □ It has been checked whether an official dedicated classification conclusion applies to the product
• □ The determination conclusion is documented in writing
• □ It has been confirmed that the veterinary exclusion does not apply, or that it does apply and this has been recorded

Regulatory information verified as of October 28, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com